Cuzzocrea S, Mazzon E, Dugo L, Caputi A P, Riley D P, Salvemini D
Institute of Pharmacology, University of Messina, Messina, Italy.
Eur J Pharmacol. 2001 Nov 30;432(1):79-89. doi: 10.1016/s0014-2999(01)01427-3.
Inflammatory bowel disease is characterised by oxidative and nitrosative stress, leukocyte infiltration, and up-regulation of intercellular adhesion molecule 1 (ICAM-1) expression in the colon. The aim of the present study was to examine the effects of M40403, a superoxide dismutase mimetic, in rats subjected to experimental colitis. Colitis was induced in rats by intracolonic instillation of trinitrobenzene sulfonic acid (TNBS). Rats experienced bloody diarrhoea and significant loss of body weight. At 4 days after TNBS administration, the colon damage was characterised by areas of mucosal necrosis. Neutrophil infiltration (indicated by myeloperoxidase activity in the mucosa) was associated with up-regulation of ICAM-1 and expression of P-selectin and high levels of malondialdehyde. Immunohistochemistry for nitrotyrosine and poly (ADP-ribose) synthetase showed an intense staining in the inflamed colon. Treatment with M40403 (5 mg/kg daily i.p.) significantly reduced the appearance of diarrhoea and the loss of body weight. This was associated with a remarkable amelioration of the disruption of the colonic architecture as well as a significant reduction of colonic myeloperoxidase activity and malondialdehyde levels. M40403 also reduced the appearance of nitrotyrosine and poly (ADP-ribose) synthetase immunoreactivity in the colon as well as reduced the up-regulation of ICAM-1 and the expression of P-selectin. The results of this study suggested that administration of a superoxide dismutase mimetic may be beneficial for treatment of inflammatory bowel disease.
炎症性肠病的特征是氧化应激和亚硝化应激、白细胞浸润以及结肠中细胞间黏附分子1(ICAM-1)表达上调。本研究的目的是检测超氧化物歧化酶模拟物M40403对实验性结肠炎大鼠的影响。通过向大鼠结肠内灌注三硝基苯磺酸(TNBS)诱导结肠炎。大鼠出现血性腹泻和体重显著减轻。在给予TNBS后4天,结肠损伤表现为黏膜坏死区域。中性粒细胞浸润(以黏膜中的髓过氧化物酶活性表示)与ICAM-1上调、P-选择素表达以及高水平丙二醛相关。硝基酪氨酸和聚(ADP-核糖)合成酶的免疫组织化学显示在发炎的结肠中有强烈染色。用M40403(每天5mg/kg腹腔注射)治疗可显著减少腹泻的出现和体重减轻。这与结肠结构破坏的明显改善以及结肠髓过氧化物酶活性和丙二醛水平的显著降低相关。M40403还减少了结肠中硝基酪氨酸和聚(ADP-核糖)合成酶免疫反应性的出现,并降低了ICAM-1的上调和P-选择素的表达。本研究结果表明,给予超氧化物歧化酶模拟物可能对炎症性肠病的治疗有益。